{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:26:19Z","timestamp":1788452779565,"version":"build-2803163510"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The global spread of carbapenemase-producing Gram-negative bacteria (CP-GNB) represents a major clinical challenge, causing severe hospital-acquired infections with limited treatment options. Accurate and rapid detection is essential for guiding antimicrobial therapy and implementing infection control measures. Lateral flow immunoassays (LFIAs) targeting the five main carbapenemase families are increasingly used in routine diagnostics, and many new commercial assays have recently become available, often without thorough assessment. The continuous evolution of these enzymes under antibiotic pressure requires regular reassessment of assay performance. Methods: In this study, we evaluated the Beright Carba-5 assay (Alltest Biotech, Hangzhou, China) targeting the five main carbapenemases (KPC, NDM, OXA-48-like, IMP, and VIM), on a panel of 77 whole-genome sequenced Gram-negative bacterial (GNB) isolates exhibiting reduced susceptibility to carbapenems. Seventy-three were carbapenemase-producing (CP) GNBs, including six VIM-, 18 OXA-48-, 14 KPC-, 9 NDM-, 8 IMP-, 10 multiple carbapenemase-, and eight non-targeted carbapenemase-producers. Results: The assay was rapid and easy to use, showing 100% (CI: 73.54% to 100%) specificity, with no false positive results. However, overall sensitivity of CP-GNB detection was lower than expected at 63.08% (CI: 50.20% to 74.72%), with numerous false negatives, particularly among IMP and NDM producers, and to a lesser extent, KPC producers. Detection was more reliable for VIM and OXA-48-like variants. Practical limitations, including insufficient buffer supply, reduced the number of tested isolates from the planned 100 to 77. Conclusions: Overall, the Beright assay demonstrated insufficient sensitivity for routine diagnostic use.<\/jats:p>","DOI":"10.3390\/diagnostics16121818","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:49:51Z","timestamp":1781257791000},"page":"1818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a Novel In Vitro Diagnostic Immunoassay for the Rapid Qualitative Detection of KPC, NDM, OXA-48-like, IMP and VIM Carbapenemases"],"prefix":"10.3390","volume":"16","author":[{"given":"Zoe","family":"Dunne","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Royal College of Surgeons (RCSI), University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland"},{"name":"Team \u2018Resist\u2019 UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Universit\u00e9 Paris-Saclay, CEA, 94270 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoussen","family":"Oueslati","sequence":"additional","affiliation":[{"name":"Team \u2018Resist\u2019 UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Universit\u00e9 Paris-Saclay, CEA, 94270 Le Kremlin-Bic\u00eatre, France"},{"name":"Bacteriology-Hygiene Unit, Bic\u00eatre Hospital, Assistance Publique-H\u00f4pitaux de Paris, 94270 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-3218","authenticated-orcid":false,"given":"Herv\u00e9","family":"Volland","sequence":"additional","affiliation":[{"name":"M\u00e9dicaments et Technologies Pour la Sant\u00e9 (MTS), Universit\u00e9 Paris-Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-9572","authenticated-orcid":false,"given":"Thierry","family":"Naas","sequence":"additional","affiliation":[{"name":"Team \u2018Resist\u2019 UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Universit\u00e9 Paris-Saclay, CEA, 94270 Le Kremlin-Bic\u00eatre, France"},{"name":"Bacteriology-Hygiene Unit, Bic\u00eatre Hospital, Assistance Publique-H\u00f4pitaux de Paris, 94270 Le Kremlin-Bic\u00eatre, France"},{"name":"French National Reference Center for Antimicrobial Resistance, 94270 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): A retrospective cohort study","volume":"17","author":"Salamanca","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to Treatment and Mortality during Mandated Emergency Care for Sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Noster, J., Thelen, P., and Hamprecht, A. (2021). Detection of Multidrug-Resistant Enterobacterales-From ESBLs to Carbapenemases. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091140"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00047-19","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of beta-Lactamase-Producing Pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14756366.2017.1344235","article-title":"Beta-lactamase database (BLDB)\u2014Structure and function","volume":"32","author":"Naas","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Boutal, H., Moguet, C., Pommies, L., Simon, S., Naas, T., and Volland, H. (2022). The Revolution of Lateral Flow Assay in the Field of AMR Detection. Diagnostics, 12.","DOI":"10.3390\/diagnostics12071744"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jac\/dkx521","article-title":"A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae","volume":"73","author":"Boutal","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/jac\/dkac264","article-title":"Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool","volume":"77","author":"Volland","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Qin, H.F., He, J.K., Chen, X., Jiang, K., Cai, X.Y., Wu, X.N., Ye, L., Chen, H.K., Guo, X.G., and Xia, Y. (2025). Evaluation of the NG-Test Carba 5 for the clinical detection of carbapenemase-producing gram-negative bacteria. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1512345"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/jac\/dkac303","article-title":"Comparison of three lateral flow immunochromatographic assays for the rapid detection of KPC, NDM, IMP, VIM and OXA-48 carbapenemases in Enterobacterales","volume":"77","author":"Bernabeu","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"dkag066","DOI":"10.1093\/jac\/dkag066","article-title":"Evaluation of the Carbapenemase Detection Kit (Colloidal Gold; Macro & Micro Test): A new immunochromatographic assay for rapid detection of carbapenemases in Enterobacterales","volume":"81","author":"Bernabeu","year":"2026","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dominguez, C.M., Oueslati, S., Al Laham, N., Nermont, R., Volland, H., and Naas, T. (2025). Comparison of Two Lateral Flow Immunochromatographic Assays for Rapid Detection of KPC, NDM, IMP, VIM and OXA-48 Carbapenemases in Gram-Negatives. Microorganisms, 13.","DOI":"10.3390\/microorganisms13092140"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/jac\/dkae239","article-title":"Evaluation of a novel lateral flow immunochromatographic assay for the rapid detection of KPC, NDM, IMP, VIM and OXA-48 carbapenemases in Gram-negatives","volume":"79","author":"Jaidane","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Falagas, M.E., Asimotou, C.M., Zidrou, M., Kontogiannis, D.S., and Filippou, C. (2025). Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review. Microorganisms, 13.","DOI":"10.3390\/microorganisms13071697"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jgar.2023.01.010","article-title":"Emergence of OXA-484, an OXA-48-type beta-lactamase, in Switzerland","volume":"32","author":"Findlay","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e0000824","DOI":"10.1128\/spectrum.00008-24","article-title":"Global emergence of double and multi-carbapenemase producing organisms: Epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence","volume":"12","author":"Yuan","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/jac\/dkaa192","article-title":"Detecting carbapenemase-producing Enterobacterales (CPE): An evaluation of an enhanced CPE infection control and screening programme in acute care","volume":"75","author":"Otter","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhin.2020.03.022","article-title":"RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: A comparative study","volume":"105","author":"Bianco","year":"2020","journal-title":"J. Hosp. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5858\/arpa.2012-0651-OA","article-title":"Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs","volume":"137","author":"Perez","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","article-title":"REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes","volume":"4","author":"Land","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jgar.2019.11.007","article-title":"Use of carbapenems in the combined treatment of emerging ceftazidime\/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature","volume":"22","author":"Cano","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhin.2021.01.015","article-title":"Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales","volume":"110","author":"Bianco","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0078521","DOI":"10.1128\/Spectrum.00785-21","article-title":"Evaluation of Rapid Immunochromatographic Tests for the Direct Detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales Isolated from Positive Blood Cultures","volume":"9","author":"Keshta","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D., and Clancy, C.J. (2023). Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin. Infect. Dis., ciad428.","DOI":"10.1093\/cid\/ciad428"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-Producing Organisms: A Global Scourge","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Fernandez-Cuenca, F., Delgado-Valverde, M., Guridi-Fernandez, P., Gimeno-Cardona, C., Hidalgo-Diaz, C., and Pascual, A. (2025). Reporting antimicrobial susceptibility and detection of carbapenemase production in single and double carbapenemase-producing Gram-negative clinical isolates: A nationwide proficiency study. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1605590"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Corcione, S., De Benedetto, I., Shbaklo, N., Ranzani, F., Mornese Pinna, S., Castiglione, A., Scabini, S., Bianco, G., Cavallo, R., and Mirabella, S. (2022). Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123268"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:43:44Z","timestamp":1781261024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16121818"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16121818","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}